Table 3. Cox proportional hazards models for PFS and OS with HFS as time-dependent covariate.
Univariate |
Multivariatea |
||||
---|---|---|---|---|---|
End point | Time-dependent variable | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value |
PFS | HFS (yes vs no) | 0.577 (0.431–0.772) | 0.0002 | 0.558 (0.409–0.760) | 0.0002 |
Grade 1 HFS | 0.639 (0.440–0.927) | 0.0184 | 0.536 (0.350–0.821) | 0.0042 | |
Grade 2 HFS | 0.481 (0.321–0.720) | 0.0004 | 0.487 (0.320–0.741) | 0.0008 | |
Grade 3 HFS | 0.641 (0.411–0.999) | 0.0495 | 0.740 (0.466–1.178) | 0.2043 | |
OS | HFS (yes vs no) | 0.417 (0.273–0.637) | <0.0001 | 0.436 (0.285–0.666) | 0.0001 |
Grade 1 HFS | 0.568 (0.334–0.968) | 0.0375 | 0.548 (0.322–0.934) | 0.0270 | |
Grade 2 HFS | 0.417 (0.227–0.765) | 0.0048 | 0.448 (0.243–0.824) | 0.0098 | |
Grade 3 HFS | 0.220 (0.093–0.520) | 0.0006 | 0.247 (0.104–0.586) | 0.0015 |
Abbreviations: CI=confidence interval; HFS=hand–foot syndrome; OS=overall survival; PFS=progression-free survival.
Grade 1 HFS was defined as minimal skin changes or dermatitis (e.g., erythema) without pain; grade 2 was defined as skin changes (e.g., peeling, blisters, bleeding, oedema) or pain, not interfering with function; and grade 3 was defined as ulcerative dermatitis or skin changes with pain interfering with function.
Significant baseline factors in multivariate models: Eastern Cooperative Oncology Group performance status (0 vs 1/2) in all models; oestrogen receptor/progesterone receptor status (any positive vs other) in both OS models.